Hgsi human genome sciences options volume alert massive call options volume on the equity down 10%

Hgsi human genome sciences options volume alert massive call options volume on the equity down 10%

HGSI Human Genome Sciences FDA Panel Review Selling off on Rumors and Speculation on Benlysta Lupus Drug “Suicide Rate” Risks. Human Genome Sciences (NASDAQ HGSI) opened at $26.00 after trading as high as $29.50 in “pre market trading”. today, the stock has hit a low of $23.68 and a high of $26.24 3.7X High Trader volume as over 10 million shares of trading so far today with another 1 hour and 50 minutes of trading remaining. The stock is down 9.86% as we wait to see how the results for Benlysta are received by the FDA. The “wall street” media hypsters are at it agai…



Hgsi human genome sciences options volume alert massive call options volume on the equity down 10%